Anaemetro I.V. Infusion 500mg Drug Use Investigation

NCT03491228 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 107

Last updated 2018-12-28

Study results available
· View outcomes & findings →

Summary

Secondary Data Collection Study; safety and effectiveness of Anaemetro under Japanese medical practice

Conditions

  • Anaerobic Infection
  • Infectious Enterocolitis
  • Amebic Dysentery

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2017-08-31
Completion
2017-08-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03491228 on ClinicalTrials.gov